Achieving Equitable Breast Cancer Care: Clinical Trials, Mental Health, and Digital Therapeutics

November 23rd 2021, 2:00pm


Discussions regarding health equity and access to care have long been implicated in breast cancer. Here, key opinion leaders discuss the latest progress in clinical trial access, digital therapeutics, and other efforts that aim to ameliorate these care gaps.

Dr Karen van Caulil: End of Oncology Care Model Could Leave Gap in Comprehensive Care

November 22nd 2021, 4:00pm


Karen L. van Caulil, PhD, president and CEO of Florida Alliance for Healthcare Value, discusses the potential gap in care that may occur with the end of the Oncology Care Model.

With No Replacement for OCM on Horizon, Oncology Practices Ask: What Now?

November 22nd 2021, 1:45pm


The announcement of a "strategic refresh" for payment models under the Center for Medicare and Medicaid Innovation offered no details on what practices should expect when the Oncology Care Model (OCM) expires in 2022.

US Oncology Network, Tennessee Oncology Tout Medicare OCM Savings

November 20th 2021, 4:38pm


A report from the Centers for Medicare and Medicaid Innovation confirmed that practices within the US Oncology Network and Tennessee Oncology participating in the Oncology Care Model (OCM) program have contributed significant savings to the agency.

Dr Funmi Olopade: Breast Cancer Screening Is Not One Size Fits All

November 20th 2021, 1:15pm


Funmi Olopade, MD, FACP, professor of medicine and human genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, explains how different populations are at different risk for breast cancer and the importance of informed screening.

Contributor: Don’t Delay—Why Now Is the Time to Reengage Patients in Routine Cancer Screenings

November 7th 2021, 1:00pm


Ignoring life-threatening, non–COVID-19 conditions for too long can turn one health crisis into another. Now is the time to resume cancer screenings, like mammograms and colonoscopies, because early detection can be lifesaving.

Consolidative Radiation Therapy Improves Progression-Free Survival in DLBCL

October 3rd 2021, 12:00pm


This new study shows that consolidative radiation therapy may be of benefit to persons with diffuse large B-cell lymphoma, both bulky and nonbulky disease.

Dr Marcus Neubauer Outlines the Benefits of the OCM and the Potential Successor Model

October 1st 2021, 3:00pm


The Oncology Care Model (OCM) was a great program that led to practice transformation and improved patient care, but there needs to be a way to address the high cost of cancer therapies, said Marcus Neubauer, MD, chief medical officer of the US Oncology Network.

Dr Elizabeth Kwo on Using Predictive Analytics to Curb Avoidable Hospitalizations During Cancer Therapy

September 29th 2021, 7:30pm


Anemia, fevers, dehydration, and other side effects from cancer treatment are all candidates for targeting with predictive analytics in an effort to care for patients are home instead of the hospital, said Elizabeth Kwo, MD, MBA, MPH, the deputy chief clinical officer at Anthem BCBS, and a speaker at the 10th anniversary of Patient-Centered Oncology Care® conference.

Surface Proteins in DLBCL Offer Therapeutic Targets

September 26th 2021, 12:15pm


Increasing knowledge of mutations and signaling proteins in diffuse large B-cell lymphoma (DLBCL) offer prognostic and therapeutic advantages, according to a review of recent findings.